Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-06-21
1985-08-27
Roberts, Elbert L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514171, 514549, 514300, 514826, 514825, 514859, A01N 4336, A61K 3140
Patent
active
045377766
ABSTRACT:
Topical pharmaceutical compositions comprising a pharmaceutically-active agent and a novel, penetration-enhancing vehicle or carrier are disclosed. The vehicle or carrier comprises a binary combination of N-(2-Hydroxyethyl) pyrrolidone and a "cell-envelope disordering compound". The compositions provide marked transepidermal and percutaneous delivery of the active selected. A method of treating certain pathologies and conditions responsive to the selected active, systemically or locally, is also disclosed.
REFERENCES:
patent: 2990331 (1961-06-01), Neumann et al.
patent: 3535422 (1970-10-01), Cox et al.
patent: 3934013 (1976-01-01), Poulsen
patent: 3989816 (1976-11-01), Rhaadhyaksha
patent: 4006218 (1977-02-01), Sipos
patent: 4017641 (1977-04-01), DiGiulio
patent: 4070462 (1978-02-01), Ecker
patent: 4075353 (1978-02-01), Mandy
patent: 4126681 (1978-11-01), Reller
patent: 4132781 (1984-09-01), Stoughton
patent: 4289764 (1981-09-01), Yarrow
patent: 4299826 (1981-11-01), Luedders
patent: 4343798 (1982-08-01), Fawzi
patent: 4423040 (1983-12-01), Rajadbyaksha
Chemical Abstracts, vol. 100 (1984), Par. 174,945k.
Stoughton, "Enhanced Percutaneous Penetration with 1-Dodecylazacycloheptan-2-One", Arch. Derm., 118, pp. 474-477, (1982).
Rosuold, J., et al., "Effect of Formulation on In Vitro Release and In Vivo Absorption of Corticosteroids from Ointments", Medd. Novsk Favm Selsk, 44, 21-45, (1982).
Anjo, D. M., et al., "Methods for Predicting Percutaneous Penetration in Man", Percutaneous Absorption of Steroids, pp. 31-51, Academic Press NY, NY, (1980).
CA 92:153,181j.
H. Barnes et al., Br. J. Derm., 93, 459, (1975).
P. J. W. Ayres et al., Br. J. Derm., 99, 307, (1978).
Schaaf and Gross, Dermatologica, 106, 357, (1953).
J. Zatz et al., J. Pharm. Sci., 67, 789, (1978).
S. K. Chandrasekaran et al., J. Pharm. Sci., 67, 1370, (1978).
B. Idson, Cosmetics & Toiletries, 95, 59, (1980).
M. M. Rieger, Cosmetics & Toiletries, 94, 32-37, (1979), and 95, 26-38, (1980).
CA 79: 122,308.
U.S. patent application Ser. No. 1,974, 1/8/79, Wickett et al.
U.S. patent application Ser. No. 383,391, 6/1/82, Cooper.
U.S. patent application Ser. No. 506,275, 6/21/83, Cooper.
U.S. patent application Ser. No. 506,274, 6/21/83, Cooper et al.
Allen George W.
Goldstein Steven J.
Roberts Elbert L.
The Procter & Gamble & Company
Witte Richard C.
LandOfFree
Penetrating topical pharmaceutical compositions containing N-(2- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Penetrating topical pharmaceutical compositions containing N-(2-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Penetrating topical pharmaceutical compositions containing N-(2- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2001239